Bitte aktiviere Javascript und schalte etwaige Werbeblocker ab

Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Suchergebnisse

Ironwood Pharmaceuticals

WKN: A0X789 / Symbol: IRWD / Name: Ironwood Pharms / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /

Ironwood Pharmaceuticals (IRWD) Q2 Earnings Top EstimatesPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

Ironwood Pharmaceuticals (IRWD) Q2 Earnings Top Estimates

Ironwood Pharmaceuticals (IRWD) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.26 per share. This compares to earnings of $0.14 per share a year ago

0

Ironwood Pharmaceuticals Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

Ironwood Pharmaceuticals Q2 Earnings Call Highlights

Key Points

Interested in Ironwood Pharmaceuticals, Inc.? Here are five stocks we like better.

LINZESS sales strengthened: U.S. second-quarter sales rose 14% to $282.3 million, prompting

0

Ironwood Q2 Earnings Beat Estimates, Revenues Lag, 2026 View RaisedPhoto, wide shot, wide-angle lens, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png

Ironwood Q2 Earnings Beat Estimates, Revenues Lag, 2026 View Raised

Ironwood Pharmaceuticals IRWD reported adjusted earnings of 31 cents per share for the second quarter of 2026, surpassing the Zacks Consensus Estimate of 26 cents. The company had reported adjusted

0

Inovio Pharma

WKN: A115GK / Symbol: INO / Name: Inovio Pharma / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

Innate Pharma

WKN: A0LCUJ / Name: Innate Pharma / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

4d Pharma plc

WKN: A1XD45 / Name: 4D Pharma / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

aTyr Pharma Inc

WKN: A2PM86 / Name: aTyr Pharma / Aktie / Biotechnologie & medizinische Forschung / Micro Cap /

ESSA Pharma Inc

WKN: A2JKQ4 / Name: ESSA / Aktie / Biotechnologie & medizinische Forschung / Micro Cap /

FSD Pharma Inc

WKN: A2JM6M / Name: FSD Pharma / Aktie / ? /

Innate Pharma S.a.

WKN: A2PSSH / Name: Innate Pharma S.a. / Aktie / ? /

N4 Pharma

WKN: A2DQES / Name: N4 Pharma / Aktie / Freizeitprodukte / Micro Cap /

Odi Pharma Ab

WKN: A2PXH6 / Name: Odi Pharma Ab / Aktie / ? /

Eql Pharma Ab

WKN: A12AZY / Name: Eql Pharma Ab / Aktie / ? /

Pila Pharma Ab

WKN: A3CT5N / Name: Pila Pharma Ab / Aktie / ? /

Evoke Pharma Inc.

WKN: A3DL9U / Symbol: EVOK / Name: Evoke Pharma / Aktie / Pharmazeutika / Micro Cap /

MEI Pharma Inc.

WKN: A3D69W / Symbol: MEIP / Name: MEI Pharma / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

Acasti Pharma Inc.

WKN: A3EP78 / Name: Acasti Pharma / Aktie / Pharmazeutika / Micro Cap /

Traws Pharma Inc.

WKN: A40PJ7 / Name: Traws Pharma Inc. / Aktie / ? /